Cargando…
A Comparison of Three Electrophysiological Methods for the Assessment of Disease Status in a Mild Spinal Muscular Atrophy Mouse Model
OBJECTIVES: There is a need for better, noninvasive quantitative biomarkers for assessing the rate of progression and possible response to therapy in spinal muscular atrophy (SMA). In this study, we compared three electrophysiological measures: compound muscle action potential (CMAP) amplitude, moto...
Autores principales: | Li, Jia, Geisbush, Tom R., Arnold, William D., Rosen, Glenn D., Zaworski, Phillip G., Rutkove, Seward B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210182/ https://www.ncbi.nlm.nih.gov/pubmed/25347197 http://dx.doi.org/10.1371/journal.pone.0111428 |
Ejemplares similares
-
Electrophysiological biomarkers in spinal muscular atrophy: proof of concept
por: David Arnold, W, et al.
Publicado: (2014) -
Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study
por: Kolb, Stephen J., et al.
Publicado: (2016) -
Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011) -
Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls
por: Czech, Christian, et al.
Publicado: (2015) -
Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)